Search company, investor...

Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
brv.com

Investments

520

Portfolio Exits

81

Funds

20

Service Providers

2

About BlueRun Ventures

BlueRun Ventures (BRV) is an early stage venture firm focused on mobile opportunities in key global markets. Since inception, BlueRun has focused on working with mobile startups to shape the ever-evolving ecosystem. They choose key geographic markets where mobile is a driving force in the way consumers and businesses interact with each other. BlueRun has offices in Menlo Park, Beijing, Shanghai, and Seoul.

Headquarters Location

545 Middlefield Road Suite 250

Menlo Park, California, 94025,

United States

650-462-7250

Want to inform investors similar to BlueRun Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing BlueRun Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find BlueRun Ventures in 1 Expert Collection, including Fitness Tech.

F

Fitness Tech

227 items

We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.

Research containing BlueRun Ventures

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned BlueRun Ventures in 4 CB Insights research briefs, most recently on Jun 9, 2021.

Latest BlueRun Ventures News

LeadArt Biotechnologies Completes US$6M Pre-A Financing

Jan 2, 2023

LeadArt Biotechnologies , a Boston, MA and Ningbo, China-based biotechnology company focused on drug discovery by automating chemoproteomics processes, raised US$6M in Pre-A funding. The round was led by BlueRun Ventures Aster. The company intends to use the funds to advance the development of its automated chemoproteomics platform and the creation of a human target-probe database. Led by CEO Feng Ni, LeadArt Biotechnologies is accelerating drug discovery by automating chemoproteomics processes and creating a human live-cell target-probe database. Its platform integrates biotechnology and automation technologies to discover disease-related targets and chemical probes for traditionally undruggable and unexplored targets. The company recently signed a strategic collaboration with AstraZeneca’s iCampus to develop a herbal medicine preclinical translation platform in Chengdu, China. FinSMEs

BlueRun Ventures Investments

520 Investments

BlueRun Ventures has made 520 investments. Their latest investment was in Leadart Technologies as part of their Seed VC - II on December 12, 2022.

CBI Logo

BlueRun Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/27/2022

Seed VC - II

Leadart Technologies

$6M

Yes

4

12/14/2022

Series A

Ruishi Health

$7.2M

Yes

1

11/24/2022

Seed VC - II

Thin Red Line

$50M

No

5

11/21/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

10/21/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/27/2022

12/14/2022

11/24/2022

11/21/2022

10/21/2022

Round

Seed VC - II

Series A

Seed VC - II

Seed VC

Seed VC

Company

Leadart Technologies

Ruishi Health

Thin Red Line

Subscribe to see more

Subscribe to see more

Amount

$6M

$7.2M

$50M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

1

5

10

10

BlueRun Ventures Portfolio Exits

81 Portfolio Exits

BlueRun Ventures has 81 portfolio exits. Their latest portfolio exit was Gennev on October 18, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/18/2022

Acquired

$99M

8

7/5/2022

Acquired

$99M

3

4/11/2022

Acquired

$99M

2

11/11/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/7/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/18/2022

7/5/2022

4/11/2022

11/11/2021

5/7/2021

Exit

Acquired

Acquired

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

8

3

2

10

10

BlueRun Ventures Fund History

20 Fund Histories

BlueRun Ventures has 20 funds, including BRV Healthcare Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/9/2019

BRV Healthcare Fund

$497.2M

1

1/16/2019

BRV VI

Early-Stage Venture Capital

Closed

$130M

8

12/31/2018

BRV Aster Fund I

Early-Stage Venture Capital

Closed

1

12/31/2016

BRV Aster Fund II

Subscribe to see more

Subscribe to see more

10

10/27/2016

BlueRun China Fund IV

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/9/2019

1/16/2019

12/31/2018

12/31/2016

10/27/2016

Fund

BRV Healthcare Fund

BRV VI

BRV Aster Fund I

BRV Aster Fund II

BlueRun China Fund IV

Fund Type

Early-Stage Venture Capital

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Closed

Closed

Subscribe to see more

Subscribe to see more

Amount

$497.2M

$130M

$99M

Sources

1

8

1

10

10

BlueRun Ventures Service Providers

2 Service Providers

BlueRun Ventures has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Provider Type

Counsel

Subscribe to see more

Service Type

General Counsel

Partnership data by VentureSource

BlueRun Ventures Team

11 Team Members

BlueRun Ventures has 11 team members, including current Founder, General Partner, John A. Malloy.

Name

Work History

Title

Status

John A. Malloy

Founder, General Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

John A. Malloy

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, General Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.